These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 14521263

  • 1. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmoulière A, Costa A.
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP, Braune AS, Porto LC, Desmoulière A, Costa AM.
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U.
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
    Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H.
    J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Altered expression of keratins during abnormal wound healing in human skin.
    Prathiba V, Rao KS, Gupta PD.
    Cytobios; 2001 Mar; 104(405):43-51. PubMed ID: 11219730
    [Abstract] [Full Text] [Related]

  • 11. [The expression of tenascin-C mRNA in keloids and hypertrophic scars].
    Han CM, He XJ, Ma Q.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):40-3. PubMed ID: 15844597
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertrophic and keloid scars fail to progress from the CD34- /α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression.
    Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S.
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [Abstract] [Full Text] [Related]

  • 15. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O, Waseem A.
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars.
    Abdou AG, Maraee AH, Al-Bara AM, Diab WM.
    Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M.
    Acta Derm Venereol; 2006 Feb; 86(4):300-7. PubMed ID: 16874413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.